IGF-1 elevation is the primary mechanism through which full HGH increases the risk of insulin resistance, fluid retention, and certain growth-related effects at high doses
What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months
We do not publish reconstitution steps publicly, because errors carry real safety risks and the process should be calibrated to a specific prescription
There is also a rule that matters for anyone in competitive sport, since AOD 9604 is prohibited by the World Anti-Doping Agency, so athletes subject to testing need to be aware before they consider it
Loti Labs supplies these compounds specifically for laboratory research use, so researchers get products that meet the quality standards for scientific research
